PIK3CA and neoplasm: The association between particularly H1047R PIK3CA mutation and better outcomes is indeed intriguing, and there could be several factors, including less aggressive phenotypes, lower histopathological tumor grade, and sensitivity to hormonal or targeted therapy, as well as presence of other mutations affecting the signaling pathway [26, 27].